China Daily Briefing

Contemporary Amperex Technology (CATL), the world's largest EV battery maker, reported record second-quarter profit, slightly missing elevated Street estimates but confirming real earnings from the green energy cycle. SCMP Business notes the numbers come as global EV demand broadens into Southeast Asian and Middle East fleet orders. Despite the beat, EV/Mobility sector closed -1.83% — the market is separating dominant platform winners like CATL from the broader supply chain, which remains capacity-oversupplied. CATL's profitability at scale is the floor for China's green-industrial thesis; if margins hold through H2 2026, it becomes the re-rating catalyst for solar, wind, and storage infrastructure names across the CSI 300.

China's securities regulator announced it will direct more medium- and long-term institutional capital into equity markets, per SCMP Business — the latest policy measure aimed at building a structurally supportive bid under A-shares. The directive targets pension funds, insurance companies, and SOE fund managers, pushing them toward higher equity allocations. This is the PBOC-adjacent demand-creation playbook: rather than cutting LPR again, regulators engineer flow. Northbound Stock Connect data will be the cross-check in coming weeks — if domestic institutional buying picks up without offsetting Southbound outflows, CSI 300 should find technical support above its current base. Watch for CSRC implementation timeline and whether allocation targets include measurable percentages.

Wall Street asset managers including BlackRock have expanded positions in WuXi AppTec, the Chinese pharmaceutical contract manufacturer, as GLP-1 weight-loss drug orders surge through its production pipeline, reports SCMP Business. This is a structural reallocation: foreign institutional money returning to a Chinese healthcare name with direct Western-facing earnings exposure, despite ongoing Biosecure Act uncertainty. The market distinguishing between WuXi-type names — with specific global pharmaceutical tailwinds — versus domestically-focused names caught in geopolitical crossfire is the playbook for navigating China exposure in 2026. BlackRock ownership sends a significant institutional credibility signal given the ongoing US-China investment scrutiny environment.